IndraLab

Statements

OTUD6B inhibits Carcinoma. 1 / 1

| 1

reach

"It has reported that OTUD6B downregulated in kidney clear cell renal cell carcinoma, kidney renal papillary cell carcinoma compared to healthy sample (Zhao G. et al., 2022), (Guo et al., 2022), and its expression level correlated with survival in VHL missense mutation patients."

40034749

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

OTUD6B inhibits Carcinoma. 1 / 1

INDRA sources:

Databases

Reading